首页> 外文OA文献 >The presence of secondary circulating prostate tumour cells determines the risk of biochemical relapse for patients with low- and intermediate-risk prostate cancer who are treated only with external radiotherapy

【2h】

The presence of secondary circulating prostate tumour cells determines the risk of biochemical relapse for patients with low- and intermediate-risk prostate cancer who are treated only with external radiotherapy

机译：次级循环前列腺肿瘤细胞的存在决定了仅与外部放射治疗治疗的低和中性风险前列腺癌患者生化复发的风险

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
相似文献
相关主题

著录项

作者
Nigel P Murray; Sócrates Aedo; Cynthia Fuentealba; Eduardo Reyes; Simone Minzer; Aníbal Salazar;
展开▼
作者单位

展开▼
年度 2018
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. The Cancer of the Prostate Risk Assessment (CAPRA) score predicts biochemical recurrence in intermediate-risk prostate cancer treated with external beam radiotherapy (EBRT) dose escalation or low-dose rate (LDR) brachytherapy. [J] . Vimal Krishnan, Guila Delouya, Jean-Paul Bahary, BJU international . 2014,第6期

机译：前列腺癌风险评估（CAPRA）分数预测了通过外部束放射疗法（EBRT）剂量递增或低剂量率（LDR）近距离放射治疗治疗的中危前列腺癌的生化复发。
2. Combining the Prostate Cancer Risk Index (PRIX) with the Presence of Secondary Circulating Prostate Cells to Predict the Risk of Biochemical Failure after Radical Prostatectomy for Prostate Cancer [J] . Nigel P Murray, Socrates Aedo, Cynthia Fuentealba, Asian Pacific Journal of Cancer Prevention . 2018,第12期

机译：结合前列腺癌风险指数（PRIX）和次级循环前列腺细胞的存在，预测前列腺癌根治性前列腺切除术后生化衰竭的风险
3. Dose-response characteristics of low- and intermediate-risk prostate cancer treated with external beam radiotherapy. [J] . Cheung R, Tucker SL, Lee AK, International Journal of Radiation Oncology, Biology, Physics . 2005,第4期

机译：外照射放疗治疗低危和中危前列腺癌的剂量反应特征。
4. The Risk for Secondary Cancers in Patients Treated for Prostate Carcinoma - An Analysis with the Competition Dose Response Model [C] . A. Dasu, I. Toma-Dasu, L. Franzen, World congress on medical physics and biomedical engineering;International congress of the IUPESM . 2011

机译：前列腺癌患者继发癌症的风险-竞争剂量反应模型的分析
5. A comparative study of quality of life in patients with low-and intermediate-risk prostate cancer treated at a single institution: Stereotactic radiotherapy vs. high dose-rate brachytherapy monotherapy vs. high dose-rate brachytherapy boost [D] . Helou, Joelle. 2017

机译：单一机构治疗的中低危前列腺癌患者生活质量的比较研究：立体定向放疗与高剂量率近距离放射疗法单药疗法与高剂量率近距离放射疗法增强
6. The presence of secondary circulating prostate tumour cells determines the risk of biochemical relapse for patients with low- and intermediate-risk prostate cancer who are treated only with external radiotherapy [O] . Nigel P Murray, Socrates Aedo, Cynthia Fuentealba, 2018

机译：二级循环前列腺肿瘤细胞的存在决定了仅接受外部放射治疗的低危和中危前列腺癌患者生化复发的风险
7. Role of Isotope Selection in Long-term Outcomes in Patients With Intermediate-risk Prostate Cancer Treated With a Combination of External Beam Radiotherapy and Low-dose-rate Interstitial Brachytherapy [O] . A. Gabriella Wernicke, Michael Shamis, Weisi Yan, 2012

机译：同位素选择在患有外梁放射治疗和低剂量间质近距离放射治疗的中间风险前列腺癌患者的长期结果中的作用
8. Randomized Phase 2 Trial of 177Lu Radiolabeled Anti-PSMA Biochemically Monoclonal Antibody J591 in Patients with High-Risk Castrate, Biochemically Relapsed Prostate Cancer [R] . Tagawa, S. T. 2010

机译：177Lu放射性标记的抗psma生化单克隆抗体J591在高风险阉割，生物化学复发的前列腺癌患者中的随机2期试验

The presence of secondary circulating prostate tumour cells determines the risk of biochemical relapse for patients with low- and intermediate-risk prostate cancer who are treated only with external radiotherapy

著录项

相似文献

相关主题

期刊订阅